AFOZX Performance — Alger Mid Cap Focus Fund, Class Z
Data updated: 2026-09-25
AFOZX returned +6.73% year to date and +13.55% over one year to Jul 2026. Annualised returns are +17.57% over 3 years and +10.13% over 5 years. The fund beat its US Mid-Cap Growth category average: $100 invested three years ago grew to $163, against $139 for the category, and to $114 over one year, against $110. Volatility over the past three years was 19.56% a year. In the 12 months to Jul 2026 the fund took in a net $11.9M, and assets reached $332.24M.
AFOZX Growth of $100
What $100 invested in Alger Mid Cap Focus Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | AFOZX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $163 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $162 | $121 |
| Since data start (Aug 2019 – Jul 2026) | $163 | $189 |
AFOZX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.73% |
| 1 year | +13.55% |
| 3 years (annualised) | +17.57% |
| 5 years (annualised) | +10.13% |
AFOZX Annual Returns
Calendar-year total returns of Alger Mid Cap Focus Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.73% |
| 2025 | +15.34% |
| 2024 | +31.93% |
| 2023 | +0.17% |
| 2022 | −0.43% |
| 2021 | +0.11% |
| 2020 | +0.66% |
| 2019 (Aug–Dec) | −0.02% |
AFOZX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.1% | −0.6% | −7.1% | +8.2% | +8.9% | +6.6% | −8.1% | — | — | — | — | — |
| 2025 | +4.8% | −8.5% | −9.6% | +1.5% | +9.4% | +8.1% | +4.2% | +1.9% | +7.9% | +0.5% | −2.7% | −1.1% |
| 2024 | +2.9% | +10.8% | +3.1% | −5.0% | +2.1% | −0.3% | −1.7% | +2.0% | +4.4% | +1.6% | +15.3% | −5.4% |
| 2023 | +0.1% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% | 0.0% | −0.1% | 0.0% | +0.1% | +0.1% |
| 2022 | −0.1% | 0.0% | 0.0% | −0.1% | −0.1% | −0.1% | +0.1% | 0.0% | −0.1% | +0.1% | 0.0% | −0.1% |
| 2021 | 0.0% | +0.1% | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% | +0.1% | 0.0% | +0.1% | −0.1% | 0.0% |
| 2020 | 0.0% | 0.0% | −0.1% | +0.2% | +0.2% | 0.0% | +0.1% | 0.0% | 0.0% | 0.0% | +0.2% | +0.1% |
| 2019 | — | — | — | — | — | — | — | 0.0% | −0.1% | 0.0% | +0.1% | 0.0% |
AFOZX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 19.56%
- 3-year Sharpe ratio: 0.67 (vs 4.5% risk-free rate)
- Best month: +15.34% (Nov 2024)
- Worst month: −9.57% (Mar 2025)
AFOZX Fund Flows
Monthly money in and out of Alger Mid Cap Focus Fund, from SEC Form N-PORT.
- 12-month net flow: $11.9M
- 12-month gross sales (incl. reinvestments): $86.9M
- Sales ÷ redemptions: 1.16×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.4M | $3.2M | $1.2M |
| Jun 2026 | $2.7M | $4.5M | −$1.8M |
| May 2026 | $2.9M | $8.6M | −$5.8M |
| Apr 2026 | $3.6M | $4.9M | −$1.3M |
| Mar 2026 | $2.7M | $9.3M | −$6.6M |
| Feb 2026 | $5.7M | $6.3M | −$605K |
| Jan 2026 | $25.7M | $4.9M | $20.8M |
| Dec 2025 | $7.0M | $13.9M | −$6.9M |
| Nov 2025 | $6.1M | $3.4M | $2.6M |
| Oct 2025 | $3.9M | $5.6M | −$1.6M |
| Sep 2025 | $10.3M | $4.5M | $5.8M |
| Aug 2025 | $11.9M | $5.9M | $6.0M |
AFOZX Assets Under Management
Net assets of Alger Mid Cap Focus Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $332.24M |
| 2026-04-30 | $317.77M |
| 2026-01-30 | $326.77M |
| 2025-10-31 | $322.67M |
| 2025-07-31 | $282.14M |
| 2025-04-30 | $231.76M |
| 2025-01-31 | $316.32M |
| 2024-10-31 | $261.38M |
| 2024-07-31 | $252.05M |
| 2024-04-30 | $271.39M |
| 2024-01-31 | $261.97M |
| 2023-10-31 | $236.76M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.